CRL

CRL Operating Cash Flow (Statement)

$582.15MTTM · USD

Period ending:

CRL FY Cash from OperationsUSD
CRL FY Cash from Operations1998-12-31: $37.38M1999-12-31: $37.57M2000-12-31: $33.77M2001-12-31: $71.30M2002-12-31: $133.66M2003-12-31: $123.77M2004-12-31: $184.83M2005-12-31: $236.70M2006-12-31: $164.37M2007-12-31: $284.25M2008-12-31: $279.95M2009-12-31: $225.04M2010-12-31: $169.01M2011-12-31: $205.28M2012-12-31: $207.90M2013-12-31: $207.14M2014-12-31: $251.05M2015-12-31: $286.36M2016-12-31: $298.32M2017-12-31: $316.27M2018-12-31: $441.14M2019-12-31: $480.94M2020-12-31: $546.58M2021-12-31: $760.80M2022-12-31: $619.64M2023-12-31: $683.90M2024-12-28: $734.58M2025-12-27: $737.65M$760.80M$0.00
1998-12-312025-12-27

Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.

CRL operating cash flow (statement) history

Net cash provided by operating activities. The available annual fiscal periods series contains 28 observations from Dec 31, 1998 to Dec 27, 2025.

Charles River Laboratories Operating Cash Flow (Statement) — Annual fiscal periods (USD)
Period endingOperating Cash Flow (Statement) (USD)
737,646,000
734,577,000
683,898,000
619,640,000
760,799,000
546,575,000
480,936,000
441,140,000
316,265,000
298,319,000
286,358,000
251,051,000
207,139,000
207,900,000
205,283,000
169,013,000
225,044,000
279,949,000
284,248,000
164,370,000
236,702,000
184,827,000
123,766,000
133,659,000
71,298,000
33,768,000
37,568,000
37,380,000

Compare operating cash flow (statement)

All CRL financial metrics · CRL stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.